Fecal Microbiota Transplant for Primary CDI

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 23, 2019

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions
Clostridium Difficile Infection
Interventions
BIOLOGICAL

Fecal microbiota transplant G3 capsules

After standard of care therapy with oral vancomycin, frozen oral FMT capsules will be provided in a formulation designed to deliver the product to the large intestine. 30 FMT capsules will be administered over a 2 hour period under direct observation

OTHER

Oral Vancomycin alone

Standard of care will be provided with oral vancomycin therapy.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER